secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANNKIND CORP (MNKD)
CIK:        0000899460
Form:       8-K
Filed at:   2023-03-27T23:59:59+00:00
Accession:  0001193125-23-080473
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MannKind appoints Lauren Sabella as EVP, Chief Operating Officer
----------------------------------------------------------------

- Appointment effective March 27, 2023; reports to CEO Michael Castagna.
- Annual base salary $440,000; target bonus 50% of base salary.
- Equity award of 210,000 RSUs vesting 25% annually over four years.
- Sabella previously COO at Acorda Therapeutics; 18-year career at Boehringer Ingelheim.
- Change of control agreement provides severance and accelerated vesting under certain conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899460/000119312523080473/0001193125-23-080473-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899460/000119312523080473/d490495d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-080473

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer